Drug Type Small molecule drug |
Synonyms XW 10508 |
Mechanism AMPA receptor antagonists(Glutamate receptor ionotropic AMPA antagonists), NMDA receptor antagonists(Glutamate [NMDA] receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization XWPharma Ltd.Startup |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pain | Phase 1 | AU | XWPharma Ltd.Startup | 28 Jun 2021 |
Depressive Disorder, Major | Phase 1 | AU | XWPharma Ltd.Startup | 20 Jun 2021 |